| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1712 | 2019 |
| Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R von Coelln, ... Movement Disorders 34 (6), 866-875, 2019 | 306 | 2019 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 195 | 2020 |
| Virus exposure and neurodegenerative disease risk across national biobanks KS Levine, HL Leonard, C Blauwendraat, H Iwaki, N Johnson, ... Neuron 111 (7), 1086-1093. e2, 2023 | 162 | 2023 |
| Genome‐wide association studies of cognitive and motor progression in Parkinson's disease MMX Tan, MA Lawton, E Jabbari, RH Reynolds, H Iwaki, C Blauwendraat, ... Movement Disorders 36 (2), 424-433, 2021 | 145 | 2021 |
| Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts H Iwaki, C Blauwendraat, HL Leonard, G Liu, J Maple-Grødem, JC Corvol, ... Neurology: Genetics 5 (4), e348, 2019 | 144 | 2019 |
| Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts H Iwaki, C Blauwendraat, HL Leonard, JJ Kim, G Liu, J Maple‐Grødem, ... Movement Disorders 34 (12), 1839-1850, 2019 | 121 | 2019 |
| Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... BioRxiv, 388165, 2019 | 97 | 2019 |
| System Genomics of Parkinson’s Disease Consortium; International Parkinson’s Disease Genomics Consortium. Identification of novel risk loci, causal insights, and heritable risk … MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... Lancet Neurol 18 (12), 1091-1102, 2019 | 95 | 2019 |
| The Parkinson's disease genome‐wide association study locus browser FP Grenn, JJ Kim, MB Makarious, H Iwaki, A Illarionova, K Brolin, ... Movement Disorders 35 (11), 2056-2067, 2020 | 88 | 2020 |
| Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease S Bandres-Ciga, S Saez-Atienzar, JJ Kim, MB Makarious, F Faghri, ... Acta neuropathologica 140, 341-358, 2020 | 87 | 2020 |
| The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ... Movement Disorders 34 (4), 460-468, 2019 | 82 | 2019 |
| Differences in the presentation and progression of Parkinson's disease by sex H Iwaki, C Blauwendraat, HL Leonard, MB Makarious, JJ Kim, G Liu, ... Movement Disorders 36 (1), 106-117, 2021 | 79 | 2021 |
| Accelerating medicines partnership: Parkinson's disease. Genetic resource H Iwaki, HL Leonard, MB Makarious, M Bookman, B Landin, D Vismer, ... Movement Disorders 36 (8), 1795-1804, 2021 | 78 | 2021 |
| Multi-modality machine learning predicting Parkinson’s disease MB Makarious, HL Leonard, D Vitale, H Iwaki, L Sargent, A Dadu, I Violich, ... npj Parkinson's Disease 8 (1), 35, 2022 | 77 | 2022 |
| Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ... Movement Disorders 35 (5), 774-780, 2020 | 64 | 2020 |
| The genetic architecture of Parkinson disease in Spain: characterizing population‐specific risk, differential haplotype structures, and providing etiologic insight S Bandres‐Ciga, S Ahmed, MS Sabir, C Blauwendraat, ... Movement Disorders 34 (12), 1851-1863, 2019 | 57 | 2019 |
| Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... BioRxiv, 388165, 2018 | 54 | 2018 |
| Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon … Y Tanabe, T Kido, T Uetani, A Kurata, T Kono, A Ogimoto, M Miyagawa, ... European radiology 26, 3790-3801, 2016 | 54 | 2016 |
| Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease H Leonard, C Blauwendraat, L Krohn, F Faghri, H Iwaki, G Ferguson, ... Journal of medical genetics 57 (5), 331-338, 2020 | 51 | 2020 |
